Fridays, MD-Led Platform

Fridays Health is a telehealth weight loss platform that takes a more bundled approach to GLP-1 care than most of its competitors. Where the dominant model in this market is medication-plus-async-support with coaching available at additional cost, Fridays includes one-on-one dietitian coaching, group Zoom coaching sessions, mental health support, and a fitness app in every subscription tier — alongside the compounded GLP-1 medication itself. The company was built on the premise that medication adherence and long-term weight maintenance require behavioral and emotional support, not just a monthly prescription. The all-inclusive structure eliminates the decision fatigue and cost accumulation that affects patients on platforms where every add-on service carries an additional line item. For patients who want a GLP-1 program that addresses lifestyle holistically, Fridays provides more infrastructure per dollar than most alternatives. Fridays prescribes compounded semaglutide and tirzepatide through partner FDA-registered compounding pharmacies. Pricing is tiered by medication type and plan length: semaglutide starts at $249/month on a month-to-month basis and falls to $150/month on a twelve-month annual plan; tirzepatide starts at $359/month and drops to $240/month annually. Unlike some platforms where price increases with dose titration, Fridays maintains consistent pricing across dose levels, which simplifies long-term budgeting. HSA and FSA cards are accepted. The platform does not accept insurance and does not prescribe brand-name GLP-1 medications such as Wegovy or Zepbound. Patients whose insurance covers brand-name drugs and who want to use that coverage should evaluate other platforms. Fridays is also subject to state regulations around compounded medication prescribing, so availability varies. Fridays competes most directly with Henry Meds, Hims, and Hers on the compounded semaglutide market, but the coaching bundle represents a meaningful differentiation for patients who want more than a prescription service. For self-motivated patients who will use the coaching and group resources, the all-inclusive model can represent strong overall value relative to assembling equivalent support piecemeal elsewhere. a fitness app in every subscription tier — alongside the compounded GLP-1 medication itself. The company was built on the premise that medication adherence and long-term weight maintenance require behavioral and emotional support, not just a monthly prescription. The all-inclusive structure eliminates the decision fatigue and cost accumulation that affects patients on platforms where every add-on service carries an additional line item. For patients who want a GLP-1 program that addresses lifestyle holistically, Fridays provides more infrastructure per dollar than most alternatives. Fridays prescribes compounded semaglutide and tirzepatide through partner FDA-registered compounding pharmacies. Pricing is tiered by medication type and plan length: semaglutide starts at $249/month on a month-to-month basis and falls to $150/month on a twelve-month annual plan; tirzepatide starts at $359/month and drops to $240/month annually. Unlike some platforms where price increases with dose titration, Fridays maintains consistent pricing across dose levels, which simplifies long-term budgeting. HSA and FSA cards are accepted. The platform does not accept insurance and does not prescribe brand-name GLP-1 medications such as Wegovy or Zepbound. Patients whose insurance covers brand-name drugs and who want to use that coverage should evaluate other platforms. Fridays is also subject to state regulations around compounded medication prescribing, so availability varies. Fridays competes most directly with Henry Meds, Hims, and Hers on the compounded semaglutide market, but the coaching bundle represents a meaningful differentiation for patients who want more than a prescription service. For self-motivated patients who will use the coaching and group resources, the all-inclusive model can represent strong overall value relative to assembling equivalent support piecemeal elsewhere.